🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Spinocerebellar Ataxia

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Autosomal Dominant Spinocerebellar Ataxias and Social Cognition NCT07099651NA1 site📍 Angers University Hospital, Angers · Tests: tests Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia NCT06692296NA1 site📍 Pieve di Soligo IRCCS Eugenio Medea · Tests: Balance training over stabilometric platform, Balance training by means of conventional rehabilitation Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia NCT05302271Phase 11 site📍 New York Weill Medical College of Cornell University · Tests: AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN… Clinical Course Of Disease In Participants With FA-CM NCT06865482n/a19 sites📍 La Jolla📍 Tampa📍 Indianapolis Lexeo Therapeutics Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain NCT05868668NA1 site📍 Cleveland The Cleveland Clinic · Tests: Focused shockwave, Radial wave, Sham treatment A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene NCT07185347Phase 39 sites📍 Angers📍 Bordeaux📍 Dijon Assistance Publique - Hôpitaux de Paris · Tests: Fampridine 10 mg prolonged-release tablet (per os), Placebo (tablets per os) Rare Disease Registry Database for Movement Disorders in Southern Anhui Province NCT07838883n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College Friedreich Ataxia Nerve Ultrasund NCT07508631n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Nerve ultrasound - routine exam Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients NCT06633003NA1 site📍 Taipei ALPS Biotech CO. LTD · Tests: Antrodia cinnamomea Products, Antrodia cinnamomea Products A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD NCT05822908Phase 1, Phase 214 sites📍 Copenhagen📍 Angers📍 Montpellier Vico Therapeutics B. V. · Tests: VO659 Riluzole in Patients With Spinocerebellar Ataxia Type 7 NCT03660917Phase 2, Phase 31 site📍 Rome S. Andrea Hospital · Tests: Riluzole, Placebo Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) NCT07215416Phase 1, Phase 21 site📍 Boston Timothy Yu · Tests: Antisense oligonucleotide targeting the ATM gene Hong Kong Spinocerebellar Ataxias Registry NCT03336008n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: no intervention Biomarker Research in Inherited Movement Disorders NCT05034172n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Clinical follow-up The EUROSCA Natural History Study NCT02440763n/a16 sites📍 Innsbruck📍 Brussels📍 Paris Ataxia Study Group A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia NCT06874010Phase 1, Phase 23 sites📍 Sydney📍 East Melbourne📍 Melbourne Design Therapeutics, Inc. · Tests: DT-216P2 Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study NCT06016946n/a34 sites📍 Los Angeles📍 Denver📍 Gainesville Friedreich's Ataxia Research Alliance Deep Brain Stimulation for Spinocerebellar Ataxia NCT07288437NA2 sites📍 San Francisco📍 San Francisco University of California, San Francisco · Tests: Deep Brain Stimulation (DBS) Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias NCT07019558NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Neurological assessment, Ophthalmological assessment Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta NCT07092358n/a2 sites📍 Hangzhou📍 Shanghai Second Affiliated Hospital, Zhejiang University, School of … · Tests: None of intervention Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias NCT01060371n/a17 sites📍 Los Angeles📍 San Francisco📍 Gainesville Lauren Moore · Tests: Genetic Testing, Blood Collection, Magnetic Resonance Imaging (MRI) Scan, Assessments and Questionnaires, Cerebrospinal… A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia NCT07778836Phase 34 sites📍 Tampa📍 Chicago📍 Eatontown Larimar Therapeutics, Inc. · Tests: Nomlabofusp, Placebo Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA) NCT02316314n/a1 site📍 New York Weill Medical College of Cornell University · Tests: Cardiac magnetic resonance imaging (CMR), Exercise-stress test, Echocardiogram (ECHO), Cardiac-related blood studies Interposed Nucleus aDBS for Ataxia NCT07325487NA1 site📍 Gainesville University of Florida · Tests: Deep Brain Stimulation An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia NCT06447025Phase 210 sites📍 Los Angeles📍 San Francisco📍 Gainesville Larimar Therapeutics, Inc. · Tests: CTI-1601 A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors NCT06623890n/a14 sites📍 Los Angeles📍 Aurora📍 Gainesville Biogen · Tests: Omaveloxolone Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia NCT07013292n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: SKYCLARYS (omaveloxolone)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy